Citations Report
Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report
Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.
Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
105 | 141 | 28 | 8 | 28 |
Year wise citations received |
543 | 553 | 590 | 563 | 587 |
| Journal total citations count | 6601 |
| Journal Impact Factor | 6.49 |
| Journal 5 years Impact Factor | 12.17 |
| Journal CiteScore | 11.19 |
| Journal h-index | 41 |
| Journal h-index since 2016 | 26 |
Luckhoff, H., L. Phahladira, F. Scheffler, L. Asmal, S. Du Plessis, B. Chiliza, S. Kilian, and R. Emsley. "Weight gain and metabolic change as predictors of symptom improvement in first-episode schizophrenia spectrum disorder patients treated over 12 months." Schizophrenia research 206 (2019): 171-176. |
|
Vita, Antonio, and Stefano Barlati. "Recovery from schizophrenia: is it possible?." Current opinion in psychiatry 31, no. 3 (2018): 246-255. |
|
Lertxundi, Unax, Rafael Hernandez, Beatriz Corcóstegui, Olatz Ibarra, Gorka Mentxaka, and Juan Medrano. "Influence of an inconsistent appearance of antipsychotics on drug adherence in patients with schizophrenia." Medicine 97, no. 44 (2018). |
|
Bibi, Nasreem, Hana Morrissey, and Patrick Ball. "A service improvement opportunity for pharmacist independent prescribers? A literature review examining the relationship between poor diabetes control and the co-existence of mental health issues." (2019). |
|
Gorczynski, Paul, Joseph Firth, Brendon Stubbs, Simon Rosenbaum, and Davy Vancampfort. "Are people with schizophrenia adherent to diabetes medication? A comparative meta-analysis." Psychiatry research 250 (2017): 17-24. |
|
Chan, Joe Kwun Nam, Corine Sau Man Wong, Philip Chi Fai Or, Eric Yu Hai Chen, and Wing Chung Chang. "Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: A population-based cohort study with 16-year follow-up." European Neuropsychopharmacology 53 (2021): 79-88. |
|
Crocq, M-A. "Histoire des traitements antipsychotiques à action prolongée dans la schizophrénie." L'Encéphale 41, no. 1 (2015): 84-92. |
|
El-Mallakh, Peggy, and Jan Findlay. "Improving Treatment Adherence in Schizophrenia." Current Treatment Options in Psychiatry 3, no. 2 (2016): 119-132. |
|
Miller, Brian J., and Peter F. Buckley. "The case for adjunctive monoclonal antibody immunotherapy in schizophrenia." Psychiatric Clinics 39, no. 2 (2016): 187-198. |
|
Insel, Catherine, Jenna Reinen, Jochen Weber, Tor D. Wager, L. Fredrik Jarskog, Daphna Shohamy, and Edward E. Smith. "Antipsychotic dose modulates behavioral and neural responses to feedback during reinforcement learning in schizophrenia." Cognitive, Affective, & Behavioral Neuroscience 14, no. 1 (2014): 189-201. |
|
Brooks, Lauren K., Nilesh Kalyanaraman, and Rana Malek. "Diabetes care for patients experiencing homelessness: beyond metformin and sulfonylureas." The American journal of medicine 132, no. 4 (2019): 408-412. |
|
Morrissette, Debbi A., and Stephen M. Stahl. "Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy." CNS spectrums 19, no. 5 (2014): 439-448. |
|
Mazza, Mario Gennaro, Sara Lucchi, Aurora Rossetti, and Massimo Clerici. "Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in non-affective psychosis: a meta-analysis and systematic review." The World Journal of Biological Psychiatry 21, no. 5 (2020): 326-338. |
|
Torres-Llenza, Vanessa, Pooja Lakshmin, and Daniel Z. Lieberman. "Spotlight on once-monthly long-acting injectable aripiprazole and its potential as maintenance treatment for bipolar I disorder in adult patients." Neuropsychiatric disease and treatment 14 (2018): 285. |
|
Poremski, Daniel, Vathsala D/O. Sagayadevan, Peizhi Wang, Alvin Lum, Mythily Subramaniam, and Chong Siow Ann. "The impact of stakeholder preferences on service user adherence to treatments for schizophrenia and metabolic comorbidities." PloS one 11, no. 11 (2016): e0166171. |
|
Ratnam, Joseline, Barbara Zdrazil, Daniela Digles, Emiliano Cuadrado-Rodriguez, Jean-Marc Neefs, Hannah Tipney, Ronald Siebes et al. "The application of the open pharmacological concepts triple store (open PHACTS) to support drug discovery research." PLoS One 9, no. 12 (2014): e115460. |
|
Taylor, Johanna, Brendon Stubbs, Catherine Hewitt, Ramzi A. Ajjan, Sarah L. Alderson, Simon Gilbody, Richard IG Holt et al. "The effectiveness of pharmacological and non-pharmacological interventions for improving glycaemic control in adults with severe mental illness: a systematic review and meta-analysis." PloS one 12, no. 1 (2017): e0168549. |
|
Robbins, T. W. "Cross?species studies of cognition relevant to drug discovery: a translational approach." British Journal of Pharmacology 174, no. 19 (2017): 3191-3199. |
|
Costello, Harry, Rebecca L. Gould, Esha Abrol, and Robert Howard. "Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder." BMJ open 9, no. 7 (2019): e027925. |
|
Fagiolini, Andrea, Emilia Alfonsi, Giovanni Amodeo, Mario Cenci, Michele Di Lella, Francesco Farinella, Fabrizio Ferraiuolo et al. "Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatrists." Expert opinion on drug safety 15, no. 4 (2016): 449-455. |
|